Tower Three Wireless SAS entered into a letter of intent to acquire Pacific Therapeutics Ltd. (DB:1P3N) from Howe and Bay Financial Corp. and other shareholders in a reverse merger transaction on August 2, 2016. Tower Three Wireless SAS entered into a share exchange agreement to acquire Pacific Therapeutics Ltd. (DB:1P3N) in a reverse merger transaction on October 20, 2016. Pacific Therapeutics will issue 30 million of its shares as consideration for the deal. The consideration shares are subject to escrow holding period. Post acquisition, combined company would be called Tower One Wireless Corp. The deal is subject to completion of a private placement of units by Pacific, to raise a minimum CAD 0.75 million and up to a maximum CAD 1.5 million at an intended price of CAD 0.15 per unit. Each Unit will consist of one common share and one common share purchase warrant. The net proceeds from the financing of CAD 2.3 million will be used for the development of the business and general working capital purposes. The transaction is also subject to all necessary regulatory approvals, approval of offer by Board of Directors of Tower Three Wireless and Pacific Therapeutics, approval of offer by shareholders of Tower Three Wireless and Pacific Therapeutics, cancellation of options and warrants, obtaining financing, third party approvals, execution of definitive agreement and consummation of due diligence investigation. Pacific has until October 30, 2016, to conduct due diligence on Tower Three, with a view to negotiating the terms of a definitive agreement in order to complete the transaction. Tower Three Wireless SAS completed the acquisition of Pacific Therapeutics Ltd. (DB:1P3N) from Howe and Bay Financial Corp. and other shareholders in a reverse merger transaction on January 12, 2017. Effective on the closing of the transaction, the Board of Directors and management of the Pacific Therapeutics was reconstituted. The Board of Directors is comprised of four members, being Alejandro Ochoa, Fabio Alexander Vasquez, Robert Horsley, and Brian Gusko and the senior management consists of Alejandro Ochoa as President and Chief Executive Officer, Abbey Abdiye as Chief Financial Officer and Octavio De La Espriella Chief Operating Officer.